A monocyte/granulocyte to lymphocyte ratio predicts survival in patients with hepatocellular carcinoma

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Zhou, Dongsheng ^a,b   Zhang, Yaojun ^a,b   Xu, Li ^a,b   Zhou, Zhongguo ^a,b   Huang, Junting ^a,b   Chen, Minshan ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; BLOOD; CARCINOMA, HEPATOCELLULAR; FEMALE; GRANULOCYTE; HUMAN; KAPLAN MEIER METHOD; LIVER NEOPLASMS; LYMPHOCYTE; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MONOCYTE; PATHOLOGY; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; GRANULOCYTES; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; MONOCYTES;

EID: 84944885684     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep15263     Document Type: Article

References (43)

1. Parkin, D. M., Bray, F., Ferlay, J., Pisani, P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 94, 153 (2001).
2. Jemal, A. et al. Global cancer statistics. CA Cancer J Clin 61, 69 (2011).
3. Simard, E. P., Ward, E. M., Siegel, R., Jemal, A. Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin (2012).
4. Colotta, F., Allavena, P., Sica, A., Garlanda, C., Mantovani, A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30, 1073 (2009).
5. Hanahan, D., Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646 (2011).
6. Walsh, S. R., Cook, E. J., Goulder, F., Justin, T. A., Keeling, N. J. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91, 181 (2005).
7. Cho, H. et al. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother 58, 15 (2009).
8. Sarraf, K. M. et al. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg 137, 425 (2009).
9. Shimada, H. et al. High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer. Gastric Cancer 13, 170 (2010).
10. Azab, B. et al. Usefulness of the neutrophil-to-lymphocyte ratio in predicting short-and long-term mortality in breast cancer patients. Ann Surg Oncol 19, 217 (2012).
11. Sharaiha, R. Z. et al. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol 18, 3362 (2011).
12. Forrest, L. M. et al. A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer 92, 1834 (2005).
13. Hashimoto, K. et al. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer 103, 1856 (2005).
14. Ishizuka, M. et al. Usefulness of a modified inflammation-based prognostic system for predicting postoperative mortality of patients undergoing surgery for primary hepatocellular carcinoma. J Surg Oncol 103, 801 (2011).
15. Kinoshita, A. et al. Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma. Br J Cancer 107, 988 (2012).
16. Kasymjanova, G. et al. The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer. Curr Oncol 17, 52 (2010).
17. Pinato, D. J., North, B. V., Sharma, R. A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI). Br J Cancer 106, 1439 (2012).
18. Smith, R. A. et al. Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg 197, 466 (2009).
19. Clarke, S. J. et al. Use of inflammatory markers to guide cancer treatment. Clin Pharmacol Ther 90, 475 (2011).
20. Proctor, M. J. et al. A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer. Br J Cancer 107, 695 (2012).
21. Szkandera, J. et al. External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients. PLoS One 8, e78225 (2013).
22. Troppan, K. et al. The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma. Br J Cancer 110, 369 (2014).
23. Dirican, A. et al. Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer? Int J Clin Oncol (2014).
24. Dirican, A. et al. The effects of hematological parameters and tumor-infiltrating lymphocytes on prognosis in patients with gastric cancer. Cancer Biomark 13, 11 (2013).
25. Bruix, J., Sherman, M. Management of hepatocellular carcinoma. Hepatology 42, 1208 (2005).
26. Davila, J. A., Morgan, R. O., Shaib, Y., McGlynn, K. A., El-Serag, H. B. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 127, 1372 (2004).
27. Mantovani, A., Allavena, P., Sica, A., Balkwill, F. Cancer-related inflammation. Nature 454, 436 (2008).
28. Coussens, L. M., Werb, Z. Inflammation and cancer. Nature 420, 860 (2002).
29. Atzpodien, J., Reitz, M. Peripheral blood neutrophils as independent immunologic predictor of response and long-term survival upon immunotherapy in metastatic renal-cell carcinoma. Cancer Biother Radiopharm 23, 129 (2008).
30. Kusumanto, Y. H., Dam, W. A., Hospers, G. A., Meijer, C., Mulder, N. H. Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis 6, 83 (2003).
31. Dunn, G. P., Old, L. J., Schreiber, R. D. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21, 137 (2004).
32. Hoffmann, T. K. et al. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clin Cancer Res 8, 2553 (2002).
33. Leitch, E. F. et al. Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. Br J Cancer 97, 1266 (2007).
34. Kim, B. W. et al. Pre-treatment diagnosis of endometrial cancer through a combination of CA125 and multiplication of neutrophil and monocyte. J Obstet Gynaecol Res 38, 48 (2012).
35. Lee, Y. Y. et al. Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level. Gynecol Oncol 124, 92 (2012).
36. Sasaki, A. et al. Prognostic value of preoperative peripheral blood monocyte count in patients with hepatocellular carcinoma. Surgery 139, 755 (2006).
37. Sasaki, A. et al. Prognostic value of preoperative peripheral blood monocyte count in patients with hepatocellular carcinoma. Surgery 139, 755 (2006).
38. Millrud, C. R. et al. The activation pattern of blood leukocytes in head and neck squamous cell carcinoma is correlated to survival. PLoS One 7, e51120 (2012).
39. Guo, Z. X. et al. [Correlation of preoperative neutrophil-to-lymphocyte ratio to prognosis of young patients with hepatocellular carcinoma]. Ai Zheng 28, 1203 (2009).
40. Wei, K., Wang, M., Zhang, W., Mu, H., Song, T. Q. Neutrophil-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma undergoing TAE combined with Sorafenib. Med Oncol 31, 969 (2014).
41. Harimoto, N. et al. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio. Transplantation 96, 1008 (2013).
42. Limaye, A. R. et al. Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma. Hepatol Res 43, 757 (2013).
43. Mano, Y. et al. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis. Ann Surg 258, 301 (2013).